President Donald Trump mused on his own reading habits, his waistline and John F. Kennedy's good looks during a new podcast interview with Second Lady Usha Vance. Early in the interview, Vance asked ...

Starting Wednesday, people on Medicare will be able to get weight loss drugs, including Wegovy and Zepbound, for $50 a month. But patients hoping for quick or permanent access to the drugs may be ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Donate to help seniors afford essentials they need today and ...

DepoSim was developed through a partnership between legal training provider AltaClaro and legal transcription provider Verbit. The makers consider the training simulator to be the first of its kind in ...

Retatrutide isn't supposed to be everywhere. Touted as the next generation in the GLP-1 craze, it's an experimental weight-loss drug that is not authorized outside of clinical trials. The Food and ...

Novatug, the innovation and R&D department of Multraship Towage & Salvage, has launched a brand new advanced simulator and training center using technology from Wärtsilä to promote safer operations ...

Megan Markoff, director of nutrition at coaching company Pallas, was scrolling Instagram when she saw a controversial post claiming “running made me fat.” She grabbed her phone and recorded a response ...

New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone.

GLP-1 weight-loss drugs like Ozempic and Wegovy are often celebrated as game-changing solutions—but new research reveals a surprising social twist. People who lose weight using these medications may ...